Merck & Co Inc
Whitehouse Station, NJ, United States
5
Total Recalls
0
Class I Recalls
1
Ongoing Recalls
Recalls by Merck & Co Inc
FDA Drug
Class II
Ongoing
Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpa
July 21, 2025
Merck & Co Inc
51,320 cartons units
FDA Drug
Class III
Terminated
Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister (NDC 66582-321-30), b) 90 count blister (NDC 66582-321-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck
January 13, 2014
Merck & Co Inc
20,259 cartons units
FDA Drug
Class III
Terminated
Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg, a) 30 count blister (NDC 66582-320-30), b) 90 count blister (NDC 66582-320-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck
January 13, 2014
Merck & Co Inc
11,175 cartons units
FDA Drug
Class III
Terminated
Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister (NDC 66582-323-30), b) 90 count blister (NDC 66582-323-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck
January 13, 2014
Merck & Co Inc
11,462 cartons units
FDA Drug
Class III
Terminated
Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg, a) 30 count blister (NDC 66582-322-30), b) 90 count blister (NDC 66582-322-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck
January 13, 2014
Merck & Co Inc
36,493 cartons units